跳至主要内容
临床试验/NCT02033200
NCT02033200已完成4 期

A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Parallel Study to Assess the Effects of Avanafil (STENDRA™) on Multiple Parameters of Vision, Including, But Not Limited to Visual Acuity, Intraocular Pressure, Pupillometry, and Color Vision Discrimination, in Healthy Male Subjects

VIVUS LLC1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
VIVUS LLC
入组人数
80
试验地点
1
主要终点
Change From Baseline in Pupil Dilation 1 Hour Post Dosing

研究概览

简要总结

The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.

详细描述

The objectives of this study are to assess the effect of Stendra on visual acuity, intraocular pressure, pupillometry, and color vision discrimination in healthy male subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy adult males 18 to 45 years of age, inclusive
  • Non-tobacco user for at least 6 months prior to first dose

排除标准

  • History or presence of retinal disease or any vision defects including color vision
  • Intraocular pressure value ≥ 22mm Hg
  • Resting heart rate < 45 or > 90 beats per minute (3 rechecks)
  • Systolic blood pressure < 90 or > 140 mm Hg or Diastolic blood pressure < 50 or >90 mm Hg (3 rechecks)
  • Initiation or change in dose of any α-blockers 14 days prior to randomization

研究组 & 干预措施

Active

Experimental

Stendra 200 mg

干预措施: Stendra 200 mg (Drug)

Active

Experimental

Stendra 200 mg

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

placebo

干预措施: Stendra 200 mg (Drug)

Placebo

Placebo Comparator

placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Change From Baseline in Pupil Dilation 1 Hour Post Dosing

时间窗: 1 hour

Pupil dilation was measured using the Neuroptics Model VIP 200 pupillometer under standard lighting conditions.

Change From Baseline in Intraocular Pressure 1 Hour Post Dosing

时间窗: 1 hour

Intraocular Pressure was measured using the Goldman applanation tonometry

Change From Baseline in Color Vision Discrimination 1 Hour Post Dosing

时间窗: 1 hour

Color vision discrimination was performed using the Lanthony 40-Hue Test according to Farnsworth-Munsell 100-Hue Test. The total error score was derived by counting the number of caps misplaced.

Change From Baseline in Visual Acuity 1 Hour Post Dosing

时间窗: 1 hour

Visual acuity was measured using the Logarithm of the Minimum Angle Resolution (LogMAR) chart. The LogMAR value of the best line read was noted and the number of letters read in the next row was multiplied by 0.02, then subtracted from the LogMAR value of the best line completely read.

次要结局

  • Change From Baseline in Color Vision Discrimination 24 Hour Post Dosing(24 hours)
  • Change From Baseline in Intraocular Pressure 24 Hour Post Dosing(24 hours)
  • Change From Baseline in Visual Acuity 24 Hours Post Dosing(24 hours)
  • Change From Baseline in Pupil Dilation 24 Hour Post Dosing(24 hour)

研究者

发起方
VIVUS LLC
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验